InnoCore’s technologies can be applied in several administration forms. Our SynBiosys® platform is compatible with state-of-the-art depot formulation technologies, like microspheres, microrods, microparticles , nanoparticles and in-situ forming implant or gels. The technology is also suitable for implants, fleece’s and for spray coating of implants, like coronary stents and other vascular devices. The InGell® technology is an advanced injectable gel drug depot system, offering un-paralleled retention and release of active pharmaceutical ingredients from a soft, localized drug depot. The InGell technology is available as a water-borne gel (hydrogel consisting of 75-90% of buffer) and a water-free gel (100% pure polymer, LiQuidPolymer™).
